Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Shares Outstanding (2020 - 2026)

Invivyd's (IVVD) quarterly Shares Outstanding (Entity) came in at $294.8 million in Q2 2026, up 145.34% on a YoY basis from $120.1 million in Q2 2025, and up 71.16% quarter-over-quarter from $172.2 million in Q4 2025.

Analysis

Invivyd (IVVD) Shares Outstanding (2020 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Shares Outstanding (Entity) for 7 consecutive years, with $294.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 145.34% year-over-year to $294.8 million; the trailing twelve-month figure through Jun 2026 stood at $294.8 million (up 145.34% YoY), and the FY2025 full-year result was $172.2 million, up 43.71% from the prior year.
  • Shares Outstanding (Entity) advanced to $294.8 million in Q2 2026 per IVVD's latest filing, from $172.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $294.8 million in Q2 2026 and bottomed at $108.8 million in Q2 2022.
  • Historically, Shares Outstanding (Entity) has averaged $131.2 million across 5 years, with a median of $119.2 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) jumped 43452.45% in 2022, then retreated 0.33% in 2023.
  • Over 5 years, Shares Outstanding (Entity) stood at $109.0 million in 2022, then grew by 1.02% to $110.2 million in 2023, then advanced by 8.78% to $119.8 million in 2024, then jumped by 43.71% to $172.2 million in 2025, then soared by 71.16% to $294.8 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $294.8 million, $172.2 million, and $170.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 540.00 Mn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 1.24 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 253.70 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 102.80 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 61.30 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 398.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 133.61 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 147.70 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 217.35 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn 320.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 320.44 Mn
Dec 31, 2025 172.21 Mn
Sep 30, 2025 170.17 Mn
Jun 30, 2025 120.02 Mn
Mar 31, 2025 119.88 Mn
Dec 31, 2024 118.56 Mn
Sep 30, 2024 119.50 Mn
Jun 30, 2024 119.36 Mn
Mar 31, 2024 115.62 Mn
Dec 31, 2023 109.53 Mn
Sep 30, 2023 109.75 Mn
Jun 30, 2023 109.45 Mn
Mar 31, 2023 108.79 Mn
Dec 31, 2022 108.27 Mn
Sep 30, 2022 108.42 Mn
Jun 30, 2022 108.17 Mn
Mar 31, 2022 107.87 Mn
Dec 31, 2021 42.62 Mn
Sep 30, 2021 61.30 Mn
Jun 30, 2021 249,769.00